targeting the burden of moderate to severe psoriasis
Published 3 years ago • 1.6K plays • Length 32:26Download video MP4
Download video MP3
Similar videos
-
39:12
taking a team-based approach to moderate to severe psoriasis in an era of expanding oral treatment
-
28:40
evidence on novel cytokine-modulating strategies in the treatment of moderate to severe psoriasis
-
49:11
realizing the potential of tyk2 inhibition to address the burden of psoriasis
-
37:46
the tyk2 pathway as a novel nonbiologic oral therapeutic option in moderate to severe psoriasis
-
29:01
addressing the global burden of atopic dermatitis: improving diagnosis, treatment, and patient care
-
43:01
addressing the burden of prurigo nodularis
-
30:10
overcoming challenges in the management of moderate to severe ad
-
58:51
taking a closer look at psoriatic disease in a new era of patient care
-
41:39
addressing the burden of polyarticular juvenile idiopathic arthritis
-
58:51
taking aim at the tyk2 pathway in psoriasis
-
1:02:10
fine-tuning the jak/stat pathway in psoriasis
-
34:05
improving outcomes for patients with moderate to severe plaque psoriasis
-
1:04:58
moderate to severe atopic dermatitis: the role and clinical utility of targeted therapy
-
2:18:22
the pathogenesis of inflammatory dermatologic disorders and rationale for targeted biologic therapy
-
58:52
novel targets for management of generalized pustular psoriasis
-
29:59
potential clinical implications of the latest data on approved and emerging therapies for psoriasis
-
25:09
targeted biologic therapy for pediatric and adult patients with moderate to severe ad
-
1:05:35
advancing care for people living with moderate to severe atopic dermatitis
-
57:06
using biologics to manage moderate to severe atopic dermatitis